| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-07 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |